[Pathogenetic therapy for strokes during the recovery period].
D015065:17-Hydroxycorticosteroids / Q000378:metabolism; D015068:17-Ketosteroids / Q000378:metabolism; D000328:Adult; D000368:Aged; D000510:Alpha-Globulins / Q000378:metabolism; D045930:Anabolic Agents / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000150:complications; D001609:Beta-Globulins / Q000378:metabolism; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D008297:Male; D008875:Middle Aged; D005719:gamma-Globulins / Q000378:metabolism
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000510:Alpha-Globulins; D045930:Anabolic Agents; D001609:Beta-Globulins; D005719:gamma-Globulins
O patogeneticheskoĭ terapii insul'ta v vosstanovitel'nom periode.